115 related articles for article (PubMed ID: 21438895)
1. Effect of depression on mortality in implantable cardioverter defibrillator recipients--findings from the prospective LICAD study.
Tzeis S; Kolb C; Baumert J; Reents T; Zrenner B; Deisenhofer I; Ronel J; Andrikopoulos G; Ladwig KH
Pacing Clin Electrophysiol; 2011 Aug; 34(8):991-7. PubMed ID: 21438895
[TBL] [Abstract][Full Text] [Related]
2. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study.
Ladwig KH; Baumert J; Marten-Mittag B; Kolb C; Zrenner B; Schmitt C
Arch Gen Psychiatry; 2008 Nov; 65(11):1324-30. PubMed ID: 18981344
[TBL] [Abstract][Full Text] [Related]
3. Relation of symptomatic heart failure and psychological status to persistent depression in patients with implantable cardioverter-defibrillator.
Pedersen SS; Hoogwegt MT; Jordaens L; Theuns DA
Am J Cardiol; 2011 Jul; 108(1):69-74. PubMed ID: 21529736
[TBL] [Abstract][Full Text] [Related]
4. Beta-blocker therapy is not associated with symptoms of depression and anxiety in patients receiving an implantable cardioverter-defibrillator.
Hoogwegt MT; Kupper N; Theuns DA; Jordaens L; Pedersen SS
Europace; 2012 Jan; 14(1):74-80. PubMed ID: 21920910
[TBL] [Abstract][Full Text] [Related]
5. Pre-implantation implantable cardioverter defibrillator concerns and Type D personality increase the risk of mortality in patients with an implantable cardioverter defibrillator.
Pedersen SS; van den Broek KC; Erdman RA; Jordaens L; Theuns DA
Europace; 2010 Oct; 12(10):1446-52. PubMed ID: 20719779
[TBL] [Abstract][Full Text] [Related]
6. Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study.
Whang W; Albert CM; Sears SF; Lampert R; Conti JB; Wang PJ; Singh JP; Ruskin JN; Muller JE; Mittleman MA;
J Am Coll Cardiol; 2005 Apr; 45(7):1090-5. PubMed ID: 15808769
[TBL] [Abstract][Full Text] [Related]
7. Characteristics associated with anxiety, depressive symptoms, and quality-of-life in a large cohort of implantable cardioverter defibrillator recipients.
Thylén I; Dekker RL; Jaarsma T; Strömberg A; Moser DK
J Psychosom Res; 2014 Aug; 77(2):122-7. PubMed ID: 25077853
[TBL] [Abstract][Full Text] [Related]
8. Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with heart failure treated with combined cardiac resynchronization plus implantable cardioverter-defibrillator therapy versus implantable cardioverter-defibrillator therapy.
Desai H; Aronow WS; Ahn C; Tsai FS; Lai HM; Gandhi K; Amin H; Frishman WH; Kalapatapu K; Cohen M; Sorbera C
J Cardiovasc Pharmacol Ther; 2010 Mar; 15(1):37-40. PubMed ID: 19966176
[TBL] [Abstract][Full Text] [Related]
9. Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks.
Pedersen SS; van Domburg RT; Theuns DA; Jordaens L; Erdman RA
Am Heart J; 2005 Apr; 149(4):664-9. PubMed ID: 15990750
[TBL] [Abstract][Full Text] [Related]
10. Type D personality is associated with increased anxiety and depressive symptoms in patients with an implantable cardioverter defibrillator and their partners.
Pedersen SS; van Domburg RT; Theuns DA; Jordaens L; Erdman RA
Psychosom Med; 2004; 66(5):714-9. PubMed ID: 15385696
[TBL] [Abstract][Full Text] [Related]
11. Depression and anxiety symptoms are associated with reduced dietary adherence in heart failure patients treated with an implantable cardioverter defibrillator.
Luyster FS; Hughes JW; Gunstad J
J Cardiovasc Nurs; 2009; 24(1):10-7. PubMed ID: 19114795
[TBL] [Abstract][Full Text] [Related]
12. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.
Rienstra M; Smit MD; Nieuwland W; Tan ES; Wiesfeld AC; Anthonio RL; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
Am Heart J; 2007 Jan; 153(1):120-6. PubMed ID: 17174649
[TBL] [Abstract][Full Text] [Related]
13. Clustering of device-related concerns and type D personality predicts increased distress in ICD patients independent of shocks.
Pedersen SS; Theuns DA; Erdman RA; Jordaens L
Pacing Clin Electrophysiol; 2008 Jan; 31(1):20-7. PubMed ID: 18181906
[TBL] [Abstract][Full Text] [Related]
14. Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study.
Marijon E; Trinquart L; Otmani A; Waintraub X; Kacet S; Clémenty J; Chatellier G; Le Heuzey JY;
Am Heart J; 2009 Feb; 157(2):391-397.e1. PubMed ID: 19185651
[TBL] [Abstract][Full Text] [Related]
15. Correlates of patient acceptance of the cardioverter defibrillator: cross-validation of the Florida Patient Acceptance Survey in Danish patients.
Pedersen SS; Spindler H; Johansen JB; Mortensen PT; Sears SF
Pacing Clin Electrophysiol; 2008 Sep; 31(9):1168-77. PubMed ID: 18834469
[TBL] [Abstract][Full Text] [Related]
16. Increased anxiety in partners of patients with a cardioverter-defibrillator: the role of indication for ICD therapy, shocks, and personality.
Pedersen SS; VAN DEN Berg M; Erdman RA; VAN Son J; Jordaens L; Theuns DA
Pacing Clin Electrophysiol; 2009 Feb; 32(2):184-92. PubMed ID: 19170907
[TBL] [Abstract][Full Text] [Related]
17. Anxiety and depression in implanted cardioverter-defibrillator recipients and heart failure: a review.
Freedenberg V; Thomas SA; Friedmann E
Heart Fail Clin; 2011 Jan; 7(1):59-68. PubMed ID: 21109208
[TBL] [Abstract][Full Text] [Related]
18. Symptomatic heart failure is the most important clinical correlate of impaired quality of life, anxiety, and depression in implantable cardioverter-defibrillator patients: a single-centre, cross-sectional study in 610 patients.
Johansen JB; Pedersen SS; Spindler H; Andersen K; Nielsen JC; Mortensen PT
Europace; 2008 May; 10(5):545-51. PubMed ID: 18378633
[TBL] [Abstract][Full Text] [Related]
19. Psychological indices as predictors for phantom shocks in implantable cardioverter defibrillator recipients.
Starrenburg A; Kraaier K; Pedersen S; Scholten M; Van Der Palen J
Pacing Clin Electrophysiol; 2014 Jun; 37(6):768-73. PubMed ID: 24456312
[TBL] [Abstract][Full Text] [Related]
20. Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention.
Chan PS; Nallamothu BK; Spertus JA; Masoudi FA; Bartone C; Kereiakes DJ; Chow T
Circ Cardiovasc Qual Outcomes; 2009 Jan; 2(1):16-24. PubMed ID: 20031808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
